James C. Gregor
339 Windermere Road, N6G 2V4
London, ON, Canada
London, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.
Journal: Pharmacogenetics and genomics
Published: April 21, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort Study.
Journal: Clinical and translational gastroenterology
Published: August 07, 2025
IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease.
Journal: Alimentary pharmacology & therapeutics
Published: May 28, 2025
Impact of CYP2C19 metabolizer status on esophageal mucosal inflammation, acid exposure, and motility among patients on chronic proton-pump inhibitor therapy with refractory symptoms of gastroesophageal reflux disease.
Journal: Journal of the Canadian Association of Gastroenterology
Published: June 06, 2024
HLADQA1∗05G>A Genetic Screening Promotes the Safe Delivery of Combination Therapy in Inflammatory Bowel Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: April 12, 2023
Clinical Guidelines for the Management of IBD.
Journal: Gastroenterology
Published: September 13, 2021
Subcutaneously Administered Anti-TNFs for the Treatment of Ulcerative Colitis: A Retrospective, Propensity Score-Matched, US Health Claims Analysis.
Journal: Advances in therapy
Published: April 21, 2021
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study.
Journal: Clinical and translational gastroenterology
Published: November 17, 2020
Crohn's Disease Is Associated with Decreased CYP3A4 and P-Glycoprotein Protein Expression.
Journal: Molecular pharmaceutics
Published: August 09, 2019
Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome.
Journal: Inflammatory bowel diseases
Published: April 17, 2019
Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: April 10, 2019
Systematic review with meta-analysis: high prevalence and cost of continued aminosalicylate use in patients with ulcerative colitis escalated to immunosuppressive and biological therapies.
Journal: Alimentary pharmacology & therapeutics
Published: September 05, 2018
Last Updated: 09/26/2026